Mercury Securities
  • Try MST28 trading from Mercury Securities with rates as low as 0.05%.
  • Earn MS Coin when you trade with MST28. Check out MST28.
  • Try MST28 trading from Mercury Securities with rates as low as 0.05%.
  • Get FREE real time quotes on our website & App. Check out MST28.
Open Trading Account
add free Download App
premium Premium Account

Last Price Change Volume
Open: Day Range: Prev Close:


MEMORANDUM OF UNDERSTANDING Bintai Kinden Corporation Berhad (BKCB or Company) - Memorandum of Understanding between BKCB and Nugenerex Immuno-Oncology on New Business Opportunity (COVID-19 Vaccine)

BINTAI KINDEN CORPORATION BERHAD

Type Announcement
Subject MEMORANDUM OF UNDERSTANDING
Description
Bintai Kinden Corporation Berhad (BKCB or Company)
- Memorandum of Understanding between BKCB and Nugenerex Immuno-Oncology on New Business Opportunity (COVID-19 Vaccine)

The Board of Directors of BKCB wishes to announce that Bintai Kinden Corporation Berhad (“BKCB”) has on 14 August 2020 entered into a Memorandum of Understanding (“MOU”) with Nugenerex Immuno-Oncology, a company incorporated in the United States of America (“GENEREX”) for establishing the preliminary understanding arrangement for the collaboration in funding, launching and management of the synthetic peptide vaccine for SARS-CoV-2 (“Vaccine”) [collectively the “Project”] subject to the terms and conditions of the MOU.

Please refer to the attachment for further details.

This announcement is dated 17 August 2020.




Please refer attachment below.



Announcement Info

Company Name BINTAI KINDEN CORPORATION BERHAD
Stock Name BINTAI
Date Announced 17 Aug 2020
Category General Announcement for PLC
Reference Number GA1-17082020-00066




Close